- Email:
High Content Screening Service
Introduction
High Content Screening (HCS) fuses automated microscopy and high-throughput informatics, combining microfluidic droplet technology with 3D human-relevant models to analyze thousands of cellular features and identify optimal compounds by solving the screening bottleneck. Creative Biolabs offers advanced HCS services with automated imaging and multi-parametric analysis, integrating microfluidics and 3D organoids to deliver granular subcellular data, high-resolution images, and predictive reports, accelerating drug discovery and bridging early research and clinical application.
Discover How We Can Help - Request a Consultation →
High Content Screening Service
High Content Screening (HCS) Service is a high-throughput, multi-parameter phenotypic analysis platform, dedicated to full-scale and quantitative evaluation of compound-induced biological effects on neural cells/tissues. Leveraging automated imaging, AI-driven image analysis, and human-relevant neural models, it realizes rapid, high-precision detection of subtle structural and functional changes of neural cells, providing intuitive and multidimensional data for neurotoxicity assessment and research.
Neurotoxicity Detection Methods
Fig.1 A variety of advanced biotechnologies and equipment are being combined with the latest achievements of high-content imaging technology.1
- Neuronal Phenotypic Analysis: Quantify neurite outgrowth, branching number, cell body morphology, and nuclear changes to evaluate structural damage of neurons induced by toxic substances.
- Glial Cell Functional Assay: Detect the activation state, proliferation, and spatial distribution of astrocytes and microglia to reflect glial-mediated neurotoxic responses.
- Synaptic and Marker Detection: Identify the expression and localization of synaptic markers (SYP, PSD95) and neural subtype markers via immunofluorescence, assessing synaptic plasticity and neuronal subtype-specific toxicity.
- Cell Viability and Apoptosis Assay: Combine multiple fluorescence labeling to simultaneously detect cell viability, early/late apoptosis, and necrosis, distinguishing cytotoxicity types and degrees.
Service Applications
| Preclinical CNS Drug Safety Screening | Evaluate the neurotoxic potential of small molecule drugs, biologics, and gene therapy products, supporting early risk elimination in drug development. |
| Environmental Chemical Neurotoxicity Assessment | Screen neurotoxic effects of industrial chemicals, pesticides, food additives, and environmental pollutants on human neural systems. |
| Neurodegenerative Disease Research | Identify compounds that induce neuronal damage similar to Alzheimer's, Parkinson's, and other diseases, and explore toxicological mechanisms of neurodegeneration. |
| High-throughput Compound Library Screening | Rapidly screen large-scale compound libraries to filter out neurotoxic candidates or discover potential neuroprotective compounds, accelerating neuropharmacological research progress. |
| Regulatory-compliant Toxicity Data Acquisition | Provide standardized, quantitative, and reproducible high-content data to support regulatory filings for drug and chemical safety evaluation. |
Workflow
Our HCS workflow is a rigorous, multi-stage process designed to maximize data extraction while maintaining high throughput.
What We Can Offer
At Creative Biolabs, we recognize that no two research projects are identical. We provide a fully customizable High Content Screening ecosystem that scales from laboratory-scale pilot studies to industrial-grade lead generation. Our service is designed to be a one-stop solution, integrating rigorous quality control with cutting-edge biological engineering.
One-stop Phenotypic Screening Service
Full-scale support from initial assay development and pilot runs to large-scale library screening.
Customized Assay Development
We optimize codon usage and genetic constructs for reporter lines and tailor fluorescent staining protocols to maximize the visualization of your specific targets.
High-Throughput Capability
Advanced automated imaging platforms capable of processing thousands of samples daily, ensuring rapid turnaround for large compound libraries.
Well-Established Quality System
Integration of Quality-by-Design (QbD) and Process Analytical Techniques (PAT) to ensure the highest data integrity and reproducibility.
Stability Guarantee
We ensure the genetic and phenotypic stability of cell lines and organoid cultures throughout long-term kinetic screening processes.
Advanced Documentation & Compliance
Every project is supported by high-standard quality control tools and documentation approved by our dedicated Quality Assurance team, following the principles of Good Manufacturing Practice (GMP).
Flexible Operating Modes
Screens can be performed in batch, fed-batch-like nutrient replenishment modes, or continuous live-cell monitoring to capture time-dependent biological events.
Experience the Creative Biolabs Advantage - Get a Quote Today →
Customer Reviews
FAQs
Q: How does HCS compare to traditional High-Throughput Screening (HTS)?
A: While HTS focuses on a single biochemical reaction (like enzyme inhibition), HCS provides a holistic view of the cell. It allows you to see where a protein is moving and how the cell's shape is changing, providing much higher predictability for clinical success.
Q: What cell types are compatible with your HCS platform?
A: We support a wide array of models, including primary cells, immortalized lines, iPSC-derived neurons, and 3D organoids. We can also assist in developing custom reporter lines using genetic editing tools.
Q: Is it possible to perform live-cell imaging over extended periods?
A: Yes, our platform includes environmental controls (CO2, temperature, humidity) that allow for kinetic, longitudinal studies to observe the real-time effects of compounds on cell behavior.
Q: How do you ensure the reproducibility of data in 3D models?
A: We use standardized New Approach Methodologies (NAMs) and automated liquid handling to minimize batch-to-batch variation, as highlighted in recent publications.
Q: Can I use my own proprietary analysis algorithms?
A: Yes. While we provide AI-driven analysis, we can also provide the raw image data (TIFF/OME-TIFF) for your internal computational teams to process using custom scripts.
Creative Biolabs offers an industry-leading High Content Screening Service that combines massive-scale library search with deep, human-relevant phenotypic analysis. Our integrated approach ensures that your leads are optimized for both potency and physiological performance.
Contact Our Team for More Information and to Discuss Your Project →
Reference
- Way, Gregory P., et al. "Evolution and impact of high content imaging." Slas Discovery 28.7 (2023): 292-305. Distributed under Open Access license CC BY 4.0, the figure was cropped. https://doi.org/10.1016/j.slasd.2023.08.009.
For Research Use Only. Not For Clinical Use.